Ethylhexyl methoxycinnamate (EHMC, CAS: 5466-77-3) is one of the most widespread UV filter used in sunscreens to protect human skin from the harmful effects of UV radiation and also as the UV absorber to prevent light-induced product degradation in many personal care products (PCPs). EHMC occurs in normal condition as trans isomer, which isomerizes during sunlight exposure to the cis-EHMC. There is evidence about adverse toxicological effects of the trans-EHMC, while the data on the toxicity of the cis-EHMC are missing. The aim of this study was to fill the data gaps about the genotoxicity of the cis-EHMC and to compare genotoxicity response of both isomers. Using experimental data, we quantified human risks focusing on the female population, which can be exposed to higher concentration of trans/cis-EHMC via dermal route, inhalation or ingestion due to major use of PCPs. UmuC test on bacterial strain Salmonella Typhimurium was used for genotoxicity evaluation of trans- and cis-EHMC. The NOEC of both isomers, calculated and extrapolated according to Qivive approach (quantitative in vitro-to-in vivo extrapolation), was used for screening probabilistic human risk assessment. The aggregate exposure distributions for trans/cis-EHMC were generated using Monte Carlo Simulations. In our study we measured genotoxic potential of both EHMC isomers to compare their genotoxicity response. The obtained NOEC values based on the experimental data: NOECtrans-EHMC = 0.064 mg ml-1 and NOECcis-EHMC = 0.038 mg ml-1 were used in probabilistic risk prediction, where cis-EHMC showed risk 1.7 times higher than trans-EHMC. Sun exposure after application of PCPs containing EHMC can lead to a much higher risk for whole population. This study brings new data on the toxicity of cis-EHMC that until now wasn't assessed. Our results showed that, due to the isomerization, the exposure to EHMC in PCPs can result in higher health risks than expected. EHMC application requires detailed reassessment.
Read full abstract